Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.47M
2: EX-10.10 Material Contract HTML 42K
3: EX-10.31 Material Contract HTML 124K
4: EX-21.1 Subsidiaries List HTML 45K
5: EX-23.1 Consent of Expert or Counsel HTML 33K
10: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 49K
Awarded Compensation
6: EX-31.1 Certification -- §302 - SOA'02 HTML 38K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 38K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 35K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 35K
16: R1 Cover Page HTML 101K
17: R2 Audit Information HTML 39K
18: R3 Consolidated Balance Sheets HTML 177K
19: R4 Consolidated Balance Sheets (Parenthetical) HTML 68K
20: R5 Consolidated Statements of Income (Loss) HTML 163K
21: R6 Consolidated Statements of Income (Loss) HTML 36K
(Parenthetical)
22: R7 Consolidated Statements of Comprehensive Income HTML 71K
(Loss)
23: R8 Consolidated Statements of Comprehensive Income HTML 39K
(Loss) (Parenthetical)
24: R9 Consolidated Statements of Changes in Redeemable HTML 99K
Preferred Stock and Shareholders' Equity (Deficit)
25: R10 Consolidated Statements of Changes in Redeemable HTML 36K
Preferred Stock and Shareholders' Equity (Deficit)
(Parenthetical)
26: R11 Consolidated Statements of Cash Flows HTML 139K
27: R12 Organization and Operations HTML 43K
28: R13 Summary of Significant Accounting Policies HTML 97K
29: R14 Restructuring Charges HTML 81K
30: R15 Medical Costs Payable HTML 58K
31: R16 Short-Term Borrowings HTML 39K
32: R17 Long-Term Borrowings and Common Stock Warrants HTML 46K
33: R18 Property, Equipment and Capitalized Software HTML 46K
34: R19 Goodwill and Intangible Assets HTML 62K
35: R20 Preferred Stock HTML 52K
36: R21 Share-Based Compensation HTML 82K
37: R22 Net Loss Per Share HTML 55K
38: R23 Benefit Plans HTML 39K
39: R24 Income Taxes HTML 91K
40: R25 Commitments and Contingencies HTML 64K
41: R26 Segment and Geographical Information HTML 100K
42: R27 Redeemable Noncontrolling Interest HTML 48K
43: R28 Aco Reach HTML 53K
44: R29 Deconsolidation of Bright Healthcare Insurance HTML 394K
Company of Texas
45: R30 Discontinued Operations HTML 394K
46: R31 Subsequent Events HTML 38K
47: R32 Condensed Financial Information HTML 112K
48: R33 Summary of Significant Accounting Policies HTML 139K
(Policies)
49: R34 Summary of Significant Accounting Policies HTML 45K
(Tables)
50: R35 Restructuring Charges (Tables) HTML 107K
51: R36 Medical Costs Payable (Tables) HTML 85K
52: R37 Long-Term Borrowings and Common Stock Warrants HTML 41K
(Tables)
53: R38 Property, Equipment and Capitalized Software HTML 53K
(Tables)
54: R39 Goodwill and Intangible Assets (Tables) HTML 65K
55: R40 Share-Based Compensation (Tables) HTML 76K
56: R41 Net Loss Per Share (Tables) HTML 57K
57: R42 Income Taxes (Tables) HTML 89K
58: R43 Commitments and Contingencies (Tables) HTML 74K
59: R44 Segment and Geographical Information (Tables) HTML 92K
60: R45 Redeemable Noncontrolling Interest (Tables) HTML 44K
61: R46 Aco Reach (Tables) HTML 45K
62: R47 Deconsolidation of Bright Healthcare Insurance HTML 246K
Company of Texas (Tables)
63: R48 Discontinued Operations (Tables) HTML 450K
64: R49 Condensed Financial Information (Tables) HTML 110K
65: R50 Organization and Operations (Details) HTML 57K
66: R51 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 138K
Narrative (Details)
67: R52 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 47K
Schedule of Operating Costs (Details)
68: R53 RESTRUCTURING CHARGES - Narrative (Details) HTML 40K
69: R54 RESTRUCTURING CHARGES - Schedule of Restructuring HTML 54K
and Related Costs (Details)
70: R55 RESTRUCTURING CHARGES - Schedule of Restructuring HTML 47K
Reserve by Type of Cost (Details)
71: R56 MEDICAL COSTS PAYABLE - Schedule of Components of HTML 56K
Change in Medical Costs Payable (Details)
72: R57 MEDICAL COSTS PAYABLE - Narrative (Details) HTML 36K
73: R58 MEDICAL COSTS PAYABLE - Components of Medical HTML 40K
Costs Payable (Details)
74: R59 Short-Term Borrowings (Details) HTML 61K
75: R60 LONG-TERM BORROWINGS AND COMMON STOCK WARRANTS - HTML 74K
Narrative (Details)
76: R61 LONG-TERM BORROWINGS AND COMMON STOCK WARRANTS - HTML 42K
Common Stock Warrants (Details)
77: R62 PROPERTY, EQUIPMENT AND CAPITALIZED SOFTWARE - HTML 49K
Schedule of Property, Equipment and Capitalized
Software (Details)
78: R63 PROPERTY, EQUIPMENT AND CAPITALIZED SOFTWARE - HTML 36K
Narrative (Details)
79: R64 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 45K
Goodwill (Details)
80: R65 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 44K
Definite-lived Intangible Assets (Details)
81: R66 GOODWILL AND INTANGIBLE ASSETS - Narrative HTML 42K
(Details)
82: R67 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 45K
Intangible Asset Amortization Expense (Details)
83: R68 Preferred Stock (Details) HTML 87K
84: R69 SHARE-BASED COMPENSATION - Narrative (Details) HTML 93K
85: R70 SHARE-BASED COMPENSATION - Schedule of Valuation HTML 45K
Assumptions for Options (Details)
86: R71 SHARE-BASED COMPENSATION - Schedule of Stock HTML 68K
Option Activity (Details)
87: R72 SHARE-BASED COMPENSATION - Schedule of RSU and PSU HTML 64K
Activity (Details)
88: R73 NET LOSS PER SHARE - Schedule of Net Loss Per HTML 88K
share (Details)
89: R74 NET LOSS PER SHARE - Schedule of Antidilutive HTML 47K
Securities Excluded From Net Loss Per Share
(Details)
90: R75 Benefit Plans (Details) HTML 39K
91: R76 INCOME TAXES - Schedule of Components of Income HTML 44K
Tax Expense (Benefit) (Details)
92: R77 INCOME TAXES - Schedule of Income Tax HTML 60K
Reconciliation (Details)
93: R78 INCOME TAXES - Reconciliation of Temporary HTML 82K
Differences Related to Deferred Tax Assets and
Liabilities (Details)
94: R79 INCOME TAXES - Narrative (Details) HTML 51K
95: R80 COMMITMENTS AND CONTINGENCIES - Narrative HTML 50K
(Details)
96: R81 COMMITMENTS AND CONTINGENCIES - Schedule of HTML 49K
Operating Lease Assets and Liabilities (Details)
97: R82 COMMITMENTS AND CONTINGENCIES - Schedule of HTML 43K
Operating Lease Supplemental Cash Flow (Details)
98: R83 COMMITMENTS AND CONTINGENCIES - Schedule of Future HTML 53K
Minimum Annual Lease Payments (Details)
99: R84 SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative HTML 50K
(Details)
100: R85 SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of HTML 102K
Segment Information (Details)
101: R86 REDEEMABLE NONCONTROLLING INTEREST - Narrative HTML 47K
(Details)
102: R87 REDEEMABLE NONCONTROLLING INTEREST - Schedule of HTML 44K
Redeemable Noncontrolling Interest (Details)
103: R88 ACO REACH - Narrative (Details) HTML 43K
104: R89 ACO REACH - Schedule Of Performance Guarantees HTML 46K
(Details)
105: R90 DECONSOLIDATION OF BRIGHT HEALTHCARE INSURANCE HTML 47K
COMPANY OF TEXAS - Narrative (Details)
106: R91 DECONSOLIDATION OF BRIGHT HEALTHCARE INSURANCE HTML 90K
COMPANY OF TEXAS - Schedule of Balance Sheet of
BHIC-Texas (Details)
107: R92 DISCONTINUED OPERATIONS - Narrative (Details) HTML 115K
108: R93 DISCONTINUED OPERATIONS - Statement of Income HTML 109K
(Loss) (Details)
109: R94 DISCONTINUED OPERATIONS - Cash Flows From HTML 42K
Operating and Investing Activities for
Discontinued Operations (Details)
110: R95 DISCONTINUED OPERATIONS - Assets and Liabilities HTML 141K
of Discontinued Operations (Details)
111: R96 DISCONTINUED OPERATIONS - Restructuring and HTML 49K
Related Costs (Details)
112: R97 DISCONTINUED OPERATIONS - Schedule of HTML 56K
Restructuring Reserve by Type of Cost (Details)
113: R98 DISCONTINUED OPERATIONS - Schedule of Investment HTML 106K
Securities (Details)
114: R99 DISCONTINUED OPERATIONS - Schedule of Liability HTML 57K
for Unpaid Claims and Claims Adjustment Expense
(Details)
115: R100 DISCONTINUED OPERATIONS - Schedule of Components HTML 63K
of Medical Costs Payable (Details)
116: R101 DISCONTINUED OPERATIONS - Total Claims Payable HTML 70K
Plus Expected Development on Reported Claims
(Details)
117: R102 DISCONTINUED OPERATIONS - Schedule of Property HTML 60K
Plant and Equipment (Details)
118: R103 DISCONTINUED OPERATIONS - Schedule of Operating HTML 42K
Lease Assets and Liabilities (Details)
119: R104 DISCONTINUED OPERATIONS - Schedule of Supplemental HTML 49K
Cash Flow and Non cash Information (Details)
120: R105 Subsequent Events (Details) HTML 41K
121: R106 CONDENSED FINANCIAL INFORMATION - Condensed HTML 133K
Balance Sheets (Details)
122: R107 CONDENSED FINANCIAL INFORMATION - Condensed HTML 76K
Balance Sheets Additional Information (Details)
123: R108 CONDENSED FINANCIAL INFORMATION - Condensed HTML 99K
Statements of Income (Loss) and Comprehensive
Income (Loss) (Details)
124: R109 CONDENSED FINANCIAL INFORMATION - Condensed HTML 79K
Statements of Cash Flow (Details)
126: XML IDEA XML File -- Filing Summary XML 236K
129: XML XBRL Instance -- neue-20231231_htm XML 3.11M
125: EXCEL IDEA Workbook of Financial Report Info XLSX 282K
12: EX-101.CAL XBRL Calculations -- neue-20231231_cal XML 382K
13: EX-101.DEF XBRL Definitions -- neue-20231231_def XML 1.28M
14: EX-101.LAB XBRL Labels -- neue-20231231_lab XML 2.21M
15: EX-101.PRE XBRL Presentations -- neue-20231231_pre XML 1.81M
11: EX-101.SCH XBRL Schema -- neue-20231231 XSD 274K
127: JSON XBRL Instance as JSON Data -- MetaLinks 686± 1.07M
128: ZIP XBRL Zipped Folder -- 0001671284-24-000028-xbrl Zip 700K
1.I have reviewed this Annual report on Form 10-K of NeueHealth, Inc. (the “registrant”);
2. Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or
persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
